BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23076912)

  • 1. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
    Deng L; Wu T; Chen XY; Xie L; Yang J
    Cochrane Database Syst Rev; 2012 Oct; 10():CD005287. PubMed ID: 23076912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
    Wu T; Chen X; Xie L
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005287. PubMed ID: 17943846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
    Lingxia X; Taixiang W; Xiaoyan C
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005287. PubMed ID: 17443581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-back therapy with GnRH analogues for uterine fibroids.
    Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective oestrogen receptor modulators (SERMs) for endometriosis.
    van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone for uterine fibroids.
    Tristan M; Orozco LJ; Steed A; Ramírez-Morera A; Stone P
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007687. PubMed ID: 22895965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol for uterine fibroids.
    Ke LQ; Yang K; Li J; Li CM
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007692. PubMed ID: 19588442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial.
    Palomba S; Russo T; Orio F; Tauchmanovà L; Zupi E; Panici PL; Nappi C; Colao A; Lombardi G; Zullo F
    Hum Reprod; 2002 Dec; 17(12):3213-9. PubMed ID: 12456626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
    Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
    Ismail SI; Bain C; Hagen S
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005292. PubMed ID: 19370619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.